Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-121974
Filing Date
2025-12-16
Accepted
2025-12-16 09:30:49
Documents
1
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6180
  Complete submission text file 0001213900-25-121974.txt   7662
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 138 CANTERBURY LN BLUE BELL PA 19422
Business Address
TRAVERSA SERGIO (Reporting) CIK: 0001565832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39082 | Film No.: 251573558